MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/toxics12070458

Медицинская библиотека · Toxics · 2024

Comparative Analysis of Therapeutic Efficacy and Adverse Reactions among Various Thrombolytic Agents.

Xie Chenxi, Zheng Naying, Li Mingmei, Zhang Zhiyang, Huang Dongqin, Xiao Meizhu, Chen Dongdong, He Chengyong, Zuo Zhenghong, Chen Xintan

СтатьяПеревод в очереди

Аннотация

Thrombosis is a major health concern that contributes to the development of several cardiovascular diseases and a significant number of fatalities worldwide. While stent surgery is the current recommended treatment according to the guidelines, percutaneous coronary intervention (PCI) is the optimal approach for acute myocardial infarction (AMI). However, in remote areas with limited resources, PCI procedures may not be feasible, leading to a delay in treatment and irreversible outcomes. In such cases, preoperative thrombolysis becomes the primary choice for managing AMI in remote settings. The market for thrombolytic drugs is continuously evolving, and identifying a safe and effective thrombolytic agent for treating AMI is crucial. This study evaluated Urokinase, Alteplase, and Recombinant Human TNK Tissue-type Plasminogen Activator for Injection (rhTNK) as representatives of first-, second-, and third-generation thrombolytic drugs, respectively. The research included in vitro thrombolysis experiments, exposure of human cardiomyocytes, zebrafish tail vein injections, and vascular endothelial transgenic zebrafish models. The findings revealed that rhTNK is the most effective thrombolytic drug with the least adverse effects and lowest bleeding rate, highlighting its potential as the preferred treatment option for AMI. The order of thrombolytic effectiveness was Urokinase < Alteplase < rhTNK, with adverse effects on cardiomyocytes post-thrombolytic therapy ranking similarly as Urokinase < Alteplase < rhTNK, while the bleeding rate after thrombolysis followed the order of Urokinase > Alteplase > rhTNK.

Для цитирования: Xie Chenxi, Zheng Naying, Li Mingmei, Zhang Zhiyang, Huang Dongqin, Xiao Meizhu, Chen Dongdong, He Chengyong, Zuo Zhenghong, Chen Xintan. Comparative Analysis of Therapeutic Efficacy and Adverse Reactions among Various Thrombolytic Agents.. Toxics. 2024. DOI: 10.3390/toxics12070458.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.